시장보고서
상품코드
1838849

매크로라이드 시장 분석 및 예측(-2034년) : 유형, 제품, 용도, 최종 사용자, 기술, 구성 요소, 배포, 형태, 디바이스

Macrolides Market Analysis and Forecast to 2034: Type, Product, Application, End User, Technology, Component, Deployment, Form, Device

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 361 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

매크로라이드 시장은 2024년 401억 달러에서 2034년에는 513억 달러로 확대되어 약 2.5%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 매크로라이드 시장은 단백질 합성을 억제하여 박테리아 감염을 치료함으로써 유명한 스트렙토마이세스 균으로부터 유래된 항생제를 포괄하고 있습니다. 이 광역 스펙트럼 약물은 호흡기 감염, 피부 감염 및 연조직 감염을 다루는 데 매우 중요합니다. 항생제 내성균 증가와 신규 제제에 대한 수요가 시장 성장을 뒷받침하고 있습니다. 혁신은 효율성 향상, 부작용 완화, 내성 극복에 중점을 둡니다. 시장은 규제 프레임워크, 연구의 진보, 헬스케어 인프라의 영향을 받아 아시아태평양과 북미가 확대를 견인하는 주요 지역이 되고 있습니다.

매크로라이드 시장은 박테리아 감염 증가와 효과적인 항생제에 대한 수요에 힘입어 강력한 성장을 이루고 있습니다. 경구 매크로라이드 제형은 환자의 편의성과 컴플라이언스의 이점에 따라 가장 호조적인 하위 부문입니다. 이 부문에서 아지트로마이신은 광역 스펙트럼에서의 효능과 치료 기간의 단축으로 두드러집니다. 매크로라이드 정주용 제제 분야에서 에리스로마이신은 특히 신속한 치료가 필요한 병원 환경에서 중요한 역할을 합니다. 매크로라이드의 동물용 용도도 기세를 늘리고 있으며, 가축의 질병 관리에 유효한 타이로신과 틸미코신이 톱입니다. 인간용 헬스케어 분야는 계속 우위를 유지하고 있지만, 동물용 헬스케어 분야도 시장 성장에 크게 공헌하는 분야로서 대두해 왔습니다. 신규 제제와 병용 요법의 개발이 시장을 더욱 끌어올릴 것으로 예측됩니다. 항생제 내성의 과제가 계속되고 있는 가운데, 선진적인 매크로라이드계 약제의 연구개발이 중시될 것으로 예측됩니다.

시장 세분화
유형 아지트로마이신, 클라리트로마이신, 에리스로마이신, 록시트로마이신, 텔리트로마이신, 디리트로마이신, 스피라마이신, 트롤렌도마이신
제품 경구 정제, 캡슐제, 현탁제, 주사제, 외용제, 분말, 과립, 젤
용도 호흡기 감염, 피부 감염, 귀 감염, 성병, 위장관 감염, 안구 감염
최종 사용자 병원, 진료소, 외래 수술 센터(ASC), 재택치료 시설, 연구소
기술 합성기술, 발효기술, 생명공학
구성 요소 원료, 부형제, 포장재
배포 병원 약국, 소매 약국, 온라인 약국
형태 고체, 액체, 반고체
장치 분무기, 흡입기

시장 현황

매크로라이드 시장은 전략적인 가격 설정과 혁신적인 제품 투입에 의해 시장 점유율이 크게 변동하는 역동적인 국면을 맞이하고 있습니다. 시장 대기업은 경쟁 구도를 이용한 가격 전략으로 점유율을 확대하는 한편, 신규 참가 기업은 참신한 제제와 전달 메커니즘으로 창조적 파괴의 상황에 있습니다. 고급 매크로라이드 유도체의 도입은 치료 효과를 높이고 시장 침투를 더욱 촉진합니다. 지역적으로는 건강 관리 투자 증가와 효과적인 항생제에 대한 수요가 증가함에 따라 신흥 시장이 견인 역할을 하고 있습니다. 매크로라이드 시장의 경쟁이 치열해지고 있으며, 주요 기업들은 경쟁력을 유지하기 위해 연구 개발에 주력하고 있습니다. 벤치마크에 의하면 견고한 파이프라인과 전략적 제휴를 가진 기업이 동업 타사를 능가하고 있다고 합니다. 특히 북미와 유럽의 규제 체제는 시장 역학을 형성하는데 매우 중요하며, 엄격한 승인 프로세스가 제품 시장의 타임라인에 영향을 미치고 있습니다. 그럼에도 불구하고 유리한 규제 변경과 항생제 개발의 가속화는 유리한 비즈니스 기회를 제공합니다. 시장 전망은 기술의 진보와 암멧 메디컬 요구를 원동력으로 성장할 전망입니다.

주요 동향과 성장 촉진요인 :

매크로라이드 시장은 박테리아 감염 증가와 효과적인 항생제에 대한 수요가 증가함에 따라 강력한 성장을 이루고 있습니다. 주요 동향으로는 효능이 향상되고 부작용이 완화된 신규 매크로라이드 제제의 개발이 포함됩니다. 항생제 내성 박테리아 증가는 유망한 치료 옵션을 제공하는 새로운 매크로라이드 유도체의 연구를 뒷받침합니다. 신흥국의 건강 관리 인프라 확장은 항생제에 대한 접근을 촉진하고 시장 성장을 더욱 촉진하고 있습니다. 또한, 박테리아 감염의 조기 진단과 치료의 중요성에 대한 의식 증가가 매크로라이드 수요를 밀어 올리고 있습니다. 새로운 항생제 개발에 대한 규제 당국의 지원은 R&D 활동에 대한 투자를 촉진하고 있습니다. 매크로라이드 항균제는 안전성 때문에 소아과 지역에서 선호됩니다. 또한 제약회사와 연구기관의 전략적 제휴가 매크로라이드 시장의 기술 혁신을 촉진하고 있습니다. 신규 약물전달 시스템에 주력하는 기업은 헬스케어 분야의 진화하는 요구에 대응하고 경쟁력을 획득할 가능성이 높습니다.

성장 억제요인과 도전 :

매크로라이드 시장은 몇 가지 중요한 성장 억제요인과 문제에 직면하고 있습니다. 주된 억제요인으로는 항생제 내성의 증대를 들 수 있으며, 이것에 의해 매크로라이드계 약제의 효능이 저하되어 수요의 감소로 이어지고 있습니다. 이러한 내성은 인간과 동물용 의약품 모두에서 과도한 사용으로 악화되고 있으며, 규제 기관이 보다 엄격한 규제를 부과하도록 촉구하고 있습니다. 새로운 매크로라이드 제제의 개발에는 높은 비용이 들기 때문에 기술 혁신이 제한된다는 경제적 압력도 한몫하고 있습니다. 중소기업은 주요 제약 회사와의 경쟁에 어려움을 겪으며 시장 성장을 더욱 저해하고 있습니다. 또한, 새로운 항생제와 비 항생제 치료와 같은 대체 요법의 출현은 엄청난 경쟁을 초래합니다. 게다가 최근 지정학적 긴장으로 악화된 세계 공급망의 혼란은 원재료 부족을 초래하여 생산 일정과 비용에 영향을 미칩니다. 마지막으로 신약의 승인 및 판매에 대한 엄격한 규제 요건은 매크로라이드계 신약 시장 투입의 복잡성과 기간을 증대시켜 신규 진출기업에 있어서 큰 장벽이 되고 있습니다.

주요 기업

Astellas Pharma, Hikma Pharmaceuticals, Sun Pharmaceutical Industries, Cipla, Dr. Reddy's Laboratories, Lupin Limited, Cadila Healthcare, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals, Wockhardt, Hetero Drugs, Aurobindo

목차

제1장 매크로라이드 시장 개요

  • 조사 목적
  • 매크로라이드 시장 정의와 조사 범위
  • 보고서의 제한 사항
  • 조사 대상 연도 및 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 매크로라이드 시장 전망

  • 매크로라이드 시장의 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 매크로라이드 시장 전략

  • 상위 시장 분석
  • 수급 분석
  • 소비자의 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 매크로라이드 시장 규모

  • 매크로라이드 시장 규모 : 금액별
  • 매크로라이드 시장 규모 : 수량별

제7장 매크로라이드 시장 : 유형별

  • 시장 개요
  • 아지트로마이신
  • 클라리트로마이신
  • 에리스로마이신
  • 록시트로마이신
  • 텔리트로마이신
  • 디리트로마이신
  • 스피라마이신
  • 트롤렌도마이신
  • 기타

제8장 매크로라이드 시장 : 제품별

  • 시장 개요
  • 경구 정제
  • 캡슐
  • 현탁액
  • 주사제
  • 외용제
  • 분말
  • 과립
  • 기타

제9장 매크로라이드 시장 : 용도별

  • 시장 개요
  • 호흡기 감염
  • 피부 감염
  • 귀 감염
  • 성병
  • 위장관 감염
  • 안구 감염
  • 기타

제10장 매크로라이드 시장 : 최종 사용자별

  • 시장 개요
  • 병원
  • 진료소
  • 외래 수술 센터(ASC)
  • 재택 의료
  • 연구소
  • 기타

제11장 매크로라이드 시장 : 기술별

  • 시장 개요
  • 합성 기술
  • 발효 기술
  • 생명공학 기술
  • 기타

제12장 매크로라이드 시장 : 구성 요소별

  • 시장 개요
  • 원약
  • 부형제
  • 포장재
  • 기타

제13장 매크로라이드 시장 : 배포별

  • 시장 개요
  • 병원 약국
  • 소매 약국
  • 온라인 약국
  • 기타

제14장 매크로라이드 시장 : 형태별

  • 시장 개요
  • 고체
  • 액체
  • 반고체
  • 기타

제15장 매크로라이드 시장 : 디바이스별

  • 시장 개요
  • 분무기
  • 흡입기
  • 기타

제16장 매크로라이드 시장 : 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 기타 중동 및 아프리카

제17장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략의 벤치마킹

제18장 기업 프로파일

  • Astellas Pharma
  • Hikma Pharmaceuticals
  • Sun Pharmaceutical Industries
  • Cipla
  • Dr. Reddy's Laboratories
  • Lupin Limited
  • Cadila Healthcare
  • Glenmark Pharmaceuticals
  • Alkem Laboratories
  • Torrent Pharmaceuticals
  • Wockhardt
  • Hetero Drugs
  • Aurobindo Pharma
  • Fresenius Kabi
  • Mylan NV
KTH 25.11.14

Macrolides Market is anticipated to expand from $40.1 billion in 2024 to $51.3 billion by 2034, growing at a CAGR of approximately 2.5%. The Macrolides Market encompasses antibiotics derived from Streptomyces bacteria, renowned for treating bacterial infections by inhibiting protein synthesis. These broad-spectrum agents are pivotal in addressing respiratory, skin, and soft tissue infections. Increasing antibiotic resistance and demand for novel formulations propel market growth. Innovations focus on improving efficacy, reducing side effects, and overcoming resistance. The market is influenced by regulatory frameworks, research advancements, and healthcare infrastructure, with Asia-Pacific and North America as key regions driving expansion.

The Macrolides Market is experiencing robust growth, fueled by the increasing prevalence of bacterial infections and the demand for effective antibiotics. The oral macrolides segment is the top-performing sub-segment, driven by its convenience and patient compliance advantages. Within this segment, azithromycin stands out due to its broad-spectrum efficacy and shorter treatment duration. The intravenous macrolides segment follows, with erythromycin being a key player, particularly in hospital settings where rapid therapeutic action is required. The veterinary applications of macrolides are also gaining momentum, with tylosin and tilmicosin leading due to their effectiveness in livestock disease management. The human healthcare sector continues to dominate, yet the animal health segment is emerging as a significant contributor to market growth. The development of novel formulations and combination therapies is anticipated to further propel the market. As antibiotic resistance challenges persist, the emphasis on research and development of advanced macrolides is expected to intensify.

Market Segmentation
TypeAzithromycin, Clarithromycin, Erythromycin, Roxithromycin, Telithromycin, Dirithromycin, Spiramycin, Troleandomycin
ProductOral Tablets, Capsules, Suspensions, Injectables, Topical Forms, Powders, Granules, Gels
ApplicationRespiratory Tract Infections, Skin Infections, Ear Infections, Sexually Transmitted Infections, Gastrointestinal Infections, Ocular Infections
End UserHospitals, Clinics, Ambulatory Surgical Centers, Homecare Settings, Research Laboratories
TechnologySynthesis Technology, Fermentation Technology, Biotechnology
ComponentActive Pharmaceutical Ingredients, Excipients, Packaging
DeploymentHospital Pharmacy, Retail Pharmacy, Online Pharmacy
FormSolid, Liquid, Semi-solid
DeviceNebulizers, Inhalers

Market Snapshot:

The Macrolides Market is witnessing a dynamic phase with significant shifts in market share influenced by strategic pricing and innovative product launches. Market leaders are leveraging competitive pricing strategies to capture a larger share, while new entrants are disrupting the landscape with novel formulations and delivery mechanisms. The introduction of advanced macrolide derivatives is enhancing therapeutic efficacy, further driving market penetration. Geographically, emerging markets are gaining traction due to increasing healthcare investments and rising demand for effective antibiotics. Competition in the Macrolides Market is intensifying, with key players focusing on R&D to maintain a competitive edge. Benchmarking reveals that companies with robust pipelines and strategic alliances are outperforming their peers. Regulatory frameworks, particularly in North America and Europe, are pivotal in shaping market dynamics, with stringent approval processes impacting product launch timelines. Nonetheless, favorable regulatory changes and expedited pathways for antibiotic development present lucrative opportunities. The market's future is poised for growth, driven by technological advancements and unmet medical needs.

Geographical Overview:

The macrolides market is witnessing diverse growth across regions, each with unique dynamics. North America leads, driven by advanced healthcare infrastructure and high antibiotic consumption. The region's focus on research and development further propels market expansion. Europe follows, benefitting from robust healthcare systems and increasing awareness of antibiotic resistance. The region's regulatory frameworks also support market growth. Asia Pacific is experiencing rapid expansion, fueled by rising healthcare expenditures and increasing demand for effective antibiotics. Emerging economies like China and India are pivotal, with growing pharmaceutical industries and healthcare reforms. Latin America presents new growth opportunities, driven by improving healthcare access and rising awareness. Countries like Brazil and Mexico are key players in this region. The Middle East & Africa are emerging markets, recognizing the importance of antibiotics in combating infectious diseases. Investments in healthcare infrastructure and initiatives to improve antibiotic accessibility are enhancing market potential. South Africa and Saudi Arabia are notable contributors to this growth.

Key Trends and Drivers:

The macrolides market is experiencing robust growth driven by increasing incidence of bacterial infections and rising demand for effective antibiotics. Key trends include the development of novel macrolide formulations with enhanced efficacy and reduced side effects. The growing prevalence of antibiotic-resistant bacteria is propelling research into new macrolide derivatives, offering promising therapeutic options. The expansion of healthcare infrastructure in emerging economies is facilitating greater access to antibiotics, further driving market growth. Additionally, the rise in awareness regarding the importance of early diagnosis and treatment of bacterial infections is boosting demand for macrolides. Regulatory support for the development of new antibiotics is encouraging investment in research and development activities. Opportunities abound in the pediatric segment, where macrolides are preferred due to their safety profile. Furthermore, strategic collaborations between pharmaceutical companies and research institutions are fostering innovation in the macrolides market. Companies focusing on novel drug delivery systems are likely to gain a competitive edge, catering to the evolving needs of the healthcare sector.

Restraints and Challenges:

The Macrolides Market is encountering several significant restraints and challenges. A primary constraint is the increasing antibiotic resistance, which diminishes the efficacy of macrolides, leading to reduced demand. This resistance is exacerbated by overuse in both human and veterinary medicine, prompting regulatory bodies to impose stricter controls. Economic pressures also play a role, as the high cost of developing new macrolide formulations limits innovation. Smaller companies struggle to compete with established pharmaceutical giants, further stifling market growth. Additionally, the emergence of alternative therapies, such as novel antibiotics and non-antibiotic treatments, presents formidable competition. Furthermore, the global supply chain disruptions, exacerbated by recent geopolitical tensions, have led to raw material shortages, affecting production timelines and costs. Lastly, stringent regulatory requirements for approval and marketing of new drugs increase the complexity and duration of bringing new macrolides to market, posing a significant barrier to entry for new players.

Key Players:

Astellas Pharma, Hikma Pharmaceuticals, Sun Pharmaceutical Industries, Cipla, Dr. Reddy's Laboratories, Lupin Limited, Cadila Healthcare, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals, Wockhardt, Hetero Drugs, Aurobindo Pharma, Fresenius Kabi, Mylan N.V.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Macrolides Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Macrolides Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Application
  • 2.6 Key Highlights of the Market, by End User
  • 2.7 Key Highlights of the Market, by Technology
  • 2.8 Key Highlights of the Market, by Component
  • 2.9 Key Highlights of the Market, by Deployment
  • 2.10 Key Highlights of the Market, by Form
  • 2.11 Key Highlights of the Market, by Device
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Application
  • 3.5 Market Attractiveness Analysis, by End User
  • 3.6 Market Attractiveness Analysis, by Technology
  • 3.7 Market Attractiveness Analysis, by Component
  • 3.8 Market Attractiveness Analysis, by Deployment
  • 3.9 Market Attractiveness Analysis, by Form
  • 3.10 Market Attractiveness Analysis, by Device
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Macrolides Market Outlook

  • 4.1 Macrolides Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Macrolides Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Macrolides Market Size

  • 6.1 Macrolides Market Size, by Value
  • 6.2 Macrolides Market Size, by Volume

7: Macrolides Market, by Type

  • 7.1 Market Overview
  • 7.2 Azithromycin
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Clarithromycin
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Erythromycin
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Roxithromycin
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Telithromycin
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Dirithromycin
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Spiramycin
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region
  • 7.9 Troleandomycin
    • 7.9.1 Key Market Trends & Opportunity Analysis
    • 7.9.2 Market Size and Forecast, by Region
  • 7.10 Others
    • 7.10.1 Key Market Trends & Opportunity Analysis
    • 7.10.2 Market Size and Forecast, by Region

8: Macrolides Market, by Product

  • 8.1 Market Overview
  • 8.2 Oral Tablets
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Capsules
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Suspensions
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Injectables
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Topical Forms
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Powders
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Granules
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Gels
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region
  • 8.10 Others
    • 8.10.1 Key Market Trends & Opportunity Analysis
    • 8.10.2 Market Size and Forecast, by Region

9: Macrolides Market, by Application

  • 9.1 Market Overview
  • 9.2 Respiratory Tract Infections
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Skin Infections
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Ear Infections
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Sexually Transmitted Infections
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Gastrointestinal Infections
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Ocular Infections
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Others
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region

10: Macrolides Market, by End User

  • 10.1 Market Overview
  • 10.2 Hospitals
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Clinics
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Ambulatory Surgical Centers
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Homecare Settings
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Research Laboratories
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Others
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region

11: Macrolides Market, by Technology

  • 11.1 Market Overview
  • 11.2 Synthesis Technology
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Fermentation Technology
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Biotechnology
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Others
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region

12: Macrolides Market, by Component

  • 12.1 Market Overview
  • 12.2 Active Pharmaceutical Ingredients
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Excipients
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Packaging
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: Macrolides Market, by Deployment

  • 13.1 Market Overview
  • 13.2 Hospital Pharmacy
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Retail Pharmacy
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Online Pharmacy
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Others
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region

14: Macrolides Market, by Form

  • 14.1 Market Overview
  • 14.2 Solid
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Liquid
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Semi-solid
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Macrolides Market, by Device

  • 15.1 Market Overview
  • 15.2 Nebulizers
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Inhalers
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: Macrolides Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Application
    • 16.2.5 North America Market Size and Forecast, by End User
    • 16.2.6 North America Market Size and Forecast, by Technology
    • 16.2.7 North America Market Size and Forecast, by Component
    • 16.2.8 North America Market Size and Forecast, by Deployment
    • 16.2.9 North America Market Size and Forecast, by Form
    • 16.2.10 North America Market Size and Forecast, by Device
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Application
      • 16.2.9.4 United States Market Size and Forecast, by End User
      • 16.2.9.5 United States Market Size and Forecast, by Technology
      • 16.2.9.6 United States Market Size and Forecast, by Component
      • 16.2.9.7 United States Market Size and Forecast, by Deployment
      • 16.2.9.8 United States Market Size and Forecast, by Form
      • 16.2.9.9 United States Market Size and Forecast, by Device
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Application
      • 16.2.10.4 Canada Market Size and Forecast, by End User
      • 16.2.10.5 Canada Market Size and Forecast, by Technology
      • 16.2.10.6 Canada Market Size and Forecast, by Component
      • 16.2.10.7 Canada Market Size and Forecast, by Deployment
      • 16.2.10.8 Canada Market Size and Forecast, by Form
      • 16.2.10.9 Canada Market Size and Forecast, by Device
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Application
    • 16.3.5 Europe Market Size and Forecast, by End User
    • 16.3.6 Europe Market Size and Forecast, by Technology
    • 16.3.7 Europe Market Size and Forecast, by Component
    • 16.3.8 Europe Market Size and Forecast, by Deployment
    • 16.3.9 Europe Market Size and Forecast, by Form
    • 16.3.10 Europe Market Size and Forecast, by Device
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.4 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Component
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Deployment
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Form
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Device
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Application
      • 16.3.10.4 Germany Market Size and Forecast, by End User
      • 16.3.10.5 Germany Market Size and Forecast, by Technology
      • 16.3.10.6 Germany Market Size and Forecast, by Component
      • 16.3.10.7 Germany Market Size and Forecast, by Deployment
      • 16.3.10.8 Germany Market Size and Forecast, by Form
      • 16.3.10.9 Germany Market Size and Forecast, by Device
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Application
      • 16.3.11.4 France Market Size and Forecast, by End User
      • 16.3.11.5 France Market Size and Forecast, by Technology
      • 16.3.11.6 France Market Size and Forecast, by Component
      • 16.3.11.7 France Market Size and Forecast, by Deployment
      • 16.3.11.8 France Market Size and Forecast, by Form
      • 16.3.11.9 France Market Size and Forecast, by Device
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Application
      • 16.3.12.4 Spain Market Size and Forecast, by End User
      • 16.3.12.5 Spain Market Size and Forecast, by Technology
      • 16.3.12.6 Spain Market Size and Forecast, by Component
      • 16.3.12.7 Spain Market Size and Forecast, by Deployment
      • 16.3.12.8 Spain Market Size and Forecast, by Form
      • 16.3.12.9 Spain Market Size and Forecast, by Device
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Application
      • 16.3.13.4 Italy Market Size and Forecast, by End User
      • 16.3.13.5 Italy Market Size and Forecast, by Technology
      • 16.3.13.6 Italy Market Size and Forecast, by Component
      • 16.3.13.7 Italy Market Size and Forecast, by Deployment
      • 16.3.13.8 Italy Market Size and Forecast, by Form
      • 16.3.13.9 Italy Market Size and Forecast, by Device
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Application
      • 16.3.14.4 Netherlands Market Size and Forecast, by End User
      • 16.3.14.5 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.6 Netherlands Market Size and Forecast, by Component
      • 16.3.14.7 Netherlands Market Size and Forecast, by Deployment
      • 16.3.14.8 Netherlands Market Size and Forecast, by Form
      • 16.3.14.9 Netherlands Market Size and Forecast, by Device
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Application
      • 16.3.15.4 Sweden Market Size and Forecast, by End User
      • 16.3.15.5 Sweden Market Size and Forecast, by Technology
      • 16.3.15.6 Sweden Market Size and Forecast, by Component
      • 16.3.15.7 Sweden Market Size and Forecast, by Deployment
      • 16.3.15.8 Sweden Market Size and Forecast, by Form
      • 16.3.15.9 Sweden Market Size and Forecast, by Device
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Application
      • 16.3.16.4 Switzerland Market Size and Forecast, by End User
      • 16.3.16.5 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.6 Switzerland Market Size and Forecast, by Component
      • 16.3.16.7 Switzerland Market Size and Forecast, by Deployment
      • 16.3.16.8 Switzerland Market Size and Forecast, by Form
      • 16.3.16.9 Switzerland Market Size and Forecast, by Device
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Application
      • 16.3.17.4 Denmark Market Size and Forecast, by End User
      • 16.3.17.5 Denmark Market Size and Forecast, by Technology
      • 16.3.17.6 Denmark Market Size and Forecast, by Component
      • 16.3.17.7 Denmark Market Size and Forecast, by Deployment
      • 16.3.17.8 Denmark Market Size and Forecast, by Form
      • 16.3.17.9 Denmark Market Size and Forecast, by Device
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Application
      • 16.3.18.4 Finland Market Size and Forecast, by End User
      • 16.3.18.5 Finland Market Size and Forecast, by Technology
      • 16.3.18.6 Finland Market Size and Forecast, by Component
      • 16.3.18.7 Finland Market Size and Forecast, by Deployment
      • 16.3.18.8 Finland Market Size and Forecast, by Form
      • 16.3.18.9 Finland Market Size and Forecast, by Device
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Application
      • 16.3.19.4 Russia Market Size and Forecast, by End User
      • 16.3.19.5 Russia Market Size and Forecast, by Technology
      • 16.3.19.6 Russia Market Size and Forecast, by Component
      • 16.3.19.7 Russia Market Size and Forecast, by Deployment
      • 16.3.19.8 Russia Market Size and Forecast, by Form
      • 16.3.19.9 Russia Market Size and Forecast, by Device
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Component
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Deployment
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Form
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Device
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.5 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Component
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Deployment
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Form
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Device
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Application
      • 16.4.9.4 China Market Size and Forecast, by End User
      • 16.4.9.5 China Market Size and Forecast, by Technology
      • 16.4.9.6 China Market Size and Forecast, by Component
      • 16.4.9.7 China Market Size and Forecast, by Deployment
      • 16.4.9.8 China Market Size and Forecast, by Form
      • 16.4.9.9 China Market Size and Forecast, by Device
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Application
      • 16.4.10.4 India Market Size and Forecast, by End User
      • 16.4.10.5 India Market Size and Forecast, by Technology
      • 16.4.10.6 India Market Size and Forecast, by Component
      • 16.4.10.7 India Market Size and Forecast, by Deployment
      • 16.4.10.8 India Market Size and Forecast, by Form
      • 16.4.10.9 India Market Size and Forecast, by Device
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Application
      • 16.4.11.4 Japan Market Size and Forecast, by End User
      • 16.4.11.5 Japan Market Size and Forecast, by Technology
      • 16.4.11.6 Japan Market Size and Forecast, by Component
      • 16.4.11.7 Japan Market Size and Forecast, by Deployment
      • 16.4.11.8 Japan Market Size and Forecast, by Form
      • 16.4.11.9 Japan Market Size and Forecast, by Device
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Application
      • 16.4.12.4 South Korea Market Size and Forecast, by End User
      • 16.4.12.5 South Korea Market Size and Forecast, by Technology
      • 16.4.12.6 South Korea Market Size and Forecast, by Component
      • 16.4.12.7 South Korea Market Size and Forecast, by Deployment
      • 16.4.12.8 South Korea Market Size and Forecast, by Form
      • 16.4.12.9 South Korea Market Size and Forecast, by Device
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Application
      • 16.4.13.4 Australia Market Size and Forecast, by End User
      • 16.4.13.5 Australia Market Size and Forecast, by Technology
      • 16.4.13.6 Australia Market Size and Forecast, by Component
      • 16.4.13.7 Australia Market Size and Forecast, by Deployment
      • 16.4.13.8 Australia Market Size and Forecast, by Form
      • 16.4.13.9 Australia Market Size and Forecast, by Device
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Application
      • 16.4.14.4 Singapore Market Size and Forecast, by End User
      • 16.4.14.5 Singapore Market Size and Forecast, by Technology
      • 16.4.14.6 Singapore Market Size and Forecast, by Component
      • 16.4.14.7 Singapore Market Size and Forecast, by Deployment
      • 16.4.14.8 Singapore Market Size and Forecast, by Form
      • 16.4.14.9 Singapore Market Size and Forecast, by Device
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Application
      • 16.4.15.4 Indonesia Market Size and Forecast, by End User
      • 16.4.15.5 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.6 Indonesia Market Size and Forecast, by Component
      • 16.4.15.7 Indonesia Market Size and Forecast, by Deployment
      • 16.4.15.8 Indonesia Market Size and Forecast, by Form
      • 16.4.15.9 Indonesia Market Size and Forecast, by Device
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Application
      • 16.4.16.4 Taiwan Market Size and Forecast, by End User
      • 16.4.16.5 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.6 Taiwan Market Size and Forecast, by Component
      • 16.4.16.7 Taiwan Market Size and Forecast, by Deployment
      • 16.4.16.8 Taiwan Market Size and Forecast, by Form
      • 16.4.16.9 Taiwan Market Size and Forecast, by Device
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Application
      • 16.4.17.4 Malaysia Market Size and Forecast, by End User
      • 16.4.17.5 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.6 Malaysia Market Size and Forecast, by Component
      • 16.4.17.7 Malaysia Market Size and Forecast, by Deployment
      • 16.4.17.8 Malaysia Market Size and Forecast, by Form
      • 16.4.17.9 Malaysia Market Size and Forecast, by Device
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Form
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Application
    • 16.5.5 Latin America Market Size and Forecast, by End User
    • 16.5.6 Latin America Market Size and Forecast, by Technology
    • 16.5.7 Latin America Market Size and Forecast, by Component
    • 16.5.8 Latin America Market Size and Forecast, by Deployment
    • 16.5.9 Latin America Market Size and Forecast, by Form
    • 16.5.10 Latin America Market Size and Forecast, by Device
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Application
      • 16.5.9.4 Brazil Market Size and Forecast, by End User
      • 16.5.9.5 Brazil Market Size and Forecast, by Technology
      • 16.5.9.6 Brazil Market Size and Forecast, by Component
      • 16.5.9.7 Brazil Market Size and Forecast, by Deployment
      • 16.5.9.8 Brazil Market Size and Forecast, by Form
      • 16.5.9.9 Brazil Market Size and Forecast, by Device
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Application
      • 16.5.10.4 Mexico Market Size and Forecast, by End User
      • 16.5.10.5 Mexico Market Size and Forecast, by Technology
      • 16.5.10.6 Mexico Market Size and Forecast, by Component
      • 16.5.10.7 Mexico Market Size and Forecast, by Deployment
      • 16.5.10.8 Mexico Market Size and Forecast, by Form
      • 16.5.10.9 Mexico Market Size and Forecast, by Device
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Application
      • 16.5.11.4 Argentina Market Size and Forecast, by End User
      • 16.5.11.5 Argentina Market Size and Forecast, by Technology
      • 16.5.11.6 Argentina Market Size and Forecast, by Component
      • 16.5.11.7 Argentina Market Size and Forecast, by Deployment
      • 16.5.11.8 Argentina Market Size and Forecast, by Form
      • 16.5.11.9 Argentina Market Size and Forecast, by Device
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Component
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Deployment
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Form
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Device
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.5 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Component
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Deployment
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Form
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Device
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Component
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Deployment
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Form
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Device
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Application
      • 16.6.10.4 UAE Market Size and Forecast, by End User
      • 16.6.10.5 UAE Market Size and Forecast, by Technology
      • 16.6.10.6 UAE Market Size and Forecast, by Component
      • 16.6.10.7 UAE Market Size and Forecast, by Deployment
      • 16.6.10.8 UAE Market Size and Forecast, by Form
      • 16.6.10.9 UAE Market Size and Forecast, by Device
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Application
      • 16.6.11.4 South Africa Market Size and Forecast, by End User
      • 16.6.11.5 South Africa Market Size and Forecast, by Technology
      • 16.6.11.6 South Africa Market Size and Forecast, by Component
      • 16.6.11.7 South Africa Market Size and Forecast, by Deployment
      • 16.6.11.8 South Africa Market Size and Forecast, by Form
      • 16.6.11.9 South Africa Market Size and Forecast, by Device
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Component
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Deployment
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Form
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Device
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Astellas Pharma
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Hikma Pharmaceuticals
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Sun Pharmaceutical Industries
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Cipla
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Dr. Reddy's Laboratories
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Lupin Limited
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Cadila Healthcare
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Glenmark Pharmaceuticals
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Alkem Laboratories
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Torrent Pharmaceuticals
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Wockhardt
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Hetero Drugs
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Aurobindo Pharma
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Fresenius Kabi
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Mylan N.V.
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제